Search

Mark C Lakshmanan

from Zionsville, IN
Age ~71
Get Report
Also known as:
Mark Chandrakant Lakshmanan, Mark G Lakshmanan, Mark Lakshanan
Phone and address:
1955 Mulsanne Dr, Zionsville, IN 46077
(317) 873-4801
Related to:
Anastasia S Lakshmanan, 33Shelley A Lakshmanan, 71
Connected to:
Deepak Lakshmanan, 43Deepak C Lakshman, 40Jananie Lakshmanan, 39Krishnamurthy Lakshman, 56Mahalakshmi Lakshmanan, 36Mohan K Lakshmanan, 47Nallakannu Lakshmanan, 68Natesh B Lakshmanan, 52Priya Lakshman, 48Punitha Lakshmanan, 48

Mark Lakshmanan Phones & Addresses

  • 1955 Mulsanne Dr, Zionsville, IN 46077 (317) 873-4801
  • 950 Williamsburg Ct, Zionsville, IN 46077 (317) 733-0557
  • Shaker Heights, OH
  • Baltimore, MD
  • Gaithersburg, MD
  • 1955 Mulsanne Dr, Zionsville, IN 46077 (317) 341-3807

Work

Position: Medical Professional

Education

School / High School: University of Maryland At Baltimore / Professional Schools 1981

Languages

English

Awards

Healthgrades Honor Roll

Ranks

Certificate: Diabetes, Metabolism & Endocrinology, 1987

Emails

g***[email protected]

Specialities

Endocrinology, Diabetes & Metabolism • Endocrinology & Metabolism

Professional Records

Medicine Doctors

Mark Lakshmanan Photo 1

Dr. Mark C Lakshmanan, Zionsville IN - MD (Doctor of Medicine)

View page
Specialties:
Endocrinology, Diabetes & Metabolism
Endocrinology & Metabolism
Address:
1955 Mulsanne Dr, Zionsville, IN 46077
(317) 873-4801 (Phone), (317) 873-4930 (Fax)
Certifications:
Diabetes, Metabolism & Endocrinology, 1987
Internal Medicine, 1984
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
University of Maryland At Baltimore / Professional Schools
Graduated: 1981
Medical School
Cleveland Metropolitan General Hospital
Graduated: 1981
Medical School
National Institutes Of Health Clinical Center
Graduated: 1981
Mark Lakshmanan Photo 2

Mark Chandrakant Lakshmanan

View page
Specialties:
Internal Medicine
Endocrinology and Metabolism
Endocrinology, Diabetes & Metabolism
Education:
University of Maryland(1981)

Resumes

Resumes

Mark Lakshmanan Photo 3

Medical Fellow At Eli Lilly & Co.

View page
Position:
Medical Fellow at Eli Lilly & Co.
Location:
Indianapolis, Indiana Area
Industry:
Pharmaceuticals
Work:
Eli Lilly & Co.
Medical Fellow
Case Western Reserve University Sep 1988 - Jun 1995
Assistant Professor of Medicine
Education:
University of Maryland School of Medicine 1977 - 1981
MD, medicine

Business Records

Name / Title
Company / Classification
Phones & Addresses
Mark Chandrakant Lakshmanan
Mark Lakshmanan MD
Nonclassifiable Establishments · Internist
1955 Mulsanne Dr, Zionsville, IN 46077
(317) 873-4801

Publications

Us Patents

Compositions And Methods For Treating Dyslipidemia

View page
US Patent:
20090137632, May 28, 2009
Filed:
Feb 2, 2006
Appl. No.:
11/813909
Inventors:
M. Johnston Erwin - Indianapolis IN, US
Mohamed Wa'el Ahned Hashad - Carmel IN, US
Mark Chandrakant Lakshmanan - Zionsville IN, US
Iris Rajman - Hampshire, GB
International Classification:
A61K 31/4535
A61P 9/10
US Classification:
514324
Abstract:
The present invention provides a method for treating dyslipidemia in a mammal, comprising administering to a mammal in need thereof, an effective amount of a compound of Formula (I): or a pharmaceutically acceptable salt or solvate thereof and at least one statin.

Methods For Lowering Platelet Counts

View page
US Patent:
61037400, Aug 15, 2000
Filed:
Aug 4, 1998
Appl. No.:
9/129324
Inventors:
Mark Chandrakant Lakshmanan - Zionsville IN
Assignee:
Eli Lilly and Company - Indianapolis IN
International Classification:
A67K 31445
US Classification:
514324
Abstract:
A method of safely lowering platelet count in a human which comprises the administration to a human in need thereof of an effective amount of a compound of formula I ##STR1## wherein R. sup. 1 and R. sup. 3 are, independently, --H, --CH. sub. 3, --CO(C. sub. 1 -C. sub. 6 alkyl), or --COAr, where Ar is optionally substituted phenyl; R. sup. 2 is selected from the group consisting of pyrrolidine, piperidine, and hexamethyleneimino; or a pharmaceutically acceptable salt or solvate thereof.

Methods For Preventing Headaches

View page
US Patent:
60082321, Dec 28, 1999
Filed:
Aug 4, 1998
Appl. No.:
9/129072
Inventors:
Mark Chandrakant Lakshmanan - Zionsville IN
Assignee:
Eli Lilly and Company - Indianapolis IN
International Classification:
A61K 3140
A61K 31445
A61K 3155
US Classification:
514324
Abstract:
A method of preventing headache in a human is disclosed which comprises the administration to a human in need thereof of an effective amount of a compound of formula I ##STR1## wherein R. sup. 1 and R. sup. 3 are, independently, --H, --CH. sub. 3, --CO(C. sub. 1 -C. sub. 6 alkyl), or --COAr, where Ar is optionally substituted phenyl; R. sup. 2 is selected from the group consisting of pyrrolidine, piperidine, and hexamethyleneimino; or a pharmaceutically acceptable salt or solvate thereof.

Therapeutic Uses Of Dulaglutide

View page
US Patent:
20200171129, Jun 4, 2020
Filed:
May 24, 2018
Appl. No.:
16/615609
Inventors:
- Indianapolis IN, US
Mark Chandrakant Lakshmanan - Zionsville IN, US
Katherine Rose Tuttle - Spokane WA, US
Alan George Zimmerman - Indianapolis IN, US
International Classification:
A61K 38/26
A61K 38/55
G01N 33/68
A61P 13/12
Abstract:
The present invention relates to methods of using dulaglutide for the treatment of chronic kidney disease in patients having moderate to late stage chronic kidney disease.
Control profile
Mark C Lakshmanan from Zionsville, IN, age ~71 Get Report